About US
Contact us
-
Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format20100429.rar source: web of FDA2010/4/29
-
FDA Removes Last CFC Inhalers from the MarketLast week, after several years of debate and review, the US Food and Drug Administration called for metered-dose inhalers to be removed from the market. Seven such inhalers, largely used to treat asth2010/4/29
-
Pro-Tect Pharma Takes Over Nectid Drug Delivery PatentsPro-Tect Pharmaceuticals has acquired multiple patents and patents-pending from Nectid, that enable three revolutionary drug delivery technologies. Pro-Tect Pharmaceuticals said that the acquired pat2010/4/28
-
ViroPharma Announces Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze(TM) (C1 Esterase Inhibitor [Human])ViroPharma Incorporated announced that it has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous adm2010/4/28
-
Synairgen plc Commences Phase II PoC Clinical Trial With Inhaled Interferon BetaSynairgen plc, a respiratory drug discovery and development company with a particular focus on viral defencse in asthma and chronic obstructive pulmonary disease (COPD), recently announced the2010/4/28
-
COVIDIEN LAUNCHES EXALGO™ EXTENDED-RELEASE TABLETSNew extended-release formulation available for around-the-clock pain management Covidien, a leading global provider of healthcare products, introduced EXALGO™ (hydromorphone HCI) Extended-Rele2010/4/27
-
Elan Corporation PLC Mulls Spinning Off Drug Delivery UnitElan Corporation, plc has decided to explore the possibility of a separation of its Elan Drug Technologies (EDT) business. If executed, any transaction would create two distinct publicly liste2010/4/27
-
FDA Approves Strativa’s Oravig Buccal Tablets for Oropharyngeal CandidiasisStrativa Pharmaceuticals recently announced that the US FDA has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis (OPC), more commonly known as thrush,2010/4/27
-
SBS Biopharmaceuticals Symposium: Exploring Synergies Across Drug FormatsSBS Biopharmaceuticals Symposium: Exploring Synergies Across Drug FormatsMay 20 - 21, 2010San Francisco Hilton Union Square San Francisco, California, USAwww.sbsonline.org/biopharmaceuticals Biophar2010/4/26
-
Colder Products Company Introduces Easy-to-Use AseptiQuik™ Connectors for Single-Use Processing at InterphexColder Products Company introduced a new sterile connector for biopharmaceutical manufacturers seeking a robust sterile connector for single-use processing. AseptiQuik™ Connectors are a reliable2010/4/26